Processa Pharmaceuticals, Inc. - stock earnings
PCSA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -2.1 million USD | ? USD |
| 2023Q2 | -2.6 million USD | ? USD |
| 2023Q1 | 166924 USD | ? USD |
| 2022Q4 | -34.4 million USD | ? USD |
| 2022Q3 | -6.0 million USD | ? USD |
| 2022Q2 | -5.2 million USD | ? USD |
| 2022Q1 | -3.2 million USD | ? USD |
| 2021Q4 | -3.2 million USD | 175398 USD |
| 2021Q3 | -3.0 million USD | ? USD |
| 2021Q2 | -3.2 million USD | ? USD |
| 2021Q1 | -2.1 million USD | ? USD |
| 2020Q4 | -9.7 million USD | -277948 USD |
| 2020Q3 | -3.1 million USD | ? USD |
| 2020Q2 | -733414 USD | ? USD |
| 2020Q1 | -874336 USD | ? USD |
| 2019Q4 | -774443 USD | ? USD |
| 2019Q3 | -863524 USD | ? USD |
| 2019Q2 | -969078 USD | ? USD |
| 2019Q1 | -750832 USD | ? USD |
| 2018Q4 | -609173 USD | ? USD |
| 2018Q3 | -852822 USD | ? USD |
| 2018Q2 | -1.2 million USD | ? USD |
| 2018Q1 | -1.5 million USD | ? USD |
| 2017Q4 | -1.5 million USD | 4365 USD |
| 2017Q3 | -75627 USD | ? USD |
| 2017Q2 | -133625 USD | 5000 USD |
| 2017Q1 | -362766 USD | -11370 USD |
| 2016Q4 | -90824 USD | ? USD |
| 2016Q3 | -68333 USD | ? USD |
| 2016Q2 | -43200 USD | ? USD |
| 2016Q1 | -133625 USD | 5000 USD |
| 2015Q4 | -295743 USD | 58165 USD |
| 2015Q3 | -295743 USD | 58165 USD |
| 2015Q2 | -2.1 million USD | 20040 USD |
| 2015Q1 | -1.5 million USD | 14400 USD |
| 2014Q4 | -1.5 million USD | 14400 USD |
| 2014Q3 | -791954 USD | 52621 USD |
| 2014Q2 | -851216 USD | 112835 USD |
| 2014Q1 | -1.3 million USD | 20345 USD |
| 2013Q4 | -806925 USD | 70090 USD |
| 2013Q3 | -718840 USD | 125910 USD |
| 2013Q2 | -726571 USD | 97280 USD |
| 2013Q1 | -816365 USD | 19200 USD |
| 2012Q4 | -790428 USD | 31451 USD |
| 2012Q3 | -601882 USD | 49058 USD |
| 2012Q2 | -475079 USD | 97022 USD |
| 2012Q1 | -580637 USD | 14614 USD |
| 2011Q4 | -600000 USD | 10000 USD |
PCSA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -21.7 million USD | ? USD |
| 2022 | -54.8 million USD | ? USD |
| 2021 | -11.4 million USD | ? USD |
| 2020 | -14.4 million USD | ? USD |
| 2019 | -3.4 million USD | ? USD |
| 2018 | -3.8 million USD | ? USD |
| 2017 | -335982 USD | 5000 USD |
| 2016 | -3.4 million USD | 113425 USD |
| 2015 | -3.4 million USD | 113425 USD |
| 2014 | -4.5 million USD | 200201 USD |
| 2013 | -3.1 million USD | 312480 USD |
| 2012 | -2.4 million USD | 192145 USD |
| 2011 | -940000 USD | 20000 USD |
| 2010 | -160000 USD | 140000 USD |
PCSA
Price: $2.17
52 week price:
Earnings Per Share: -22.80 USD
P/E Ratio: -0.11
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 125600
Market Capitalization: 3.1 million